Zumutor has successfully filed 6 PCT and several provisional applications encompassing the technology platform and products. Our Antibody display technology platforms and products thereof are adequately covered for future licensing. In addition, our platforms are innovative, and have therefore resulted in multiple applications. All products from our pipeline will be considered as New Biological Entities and new IP applications will be ﬁled. Our aim is to create a powerful IP portfolio around our technologies and products for licensing and/or collaborations.
Zumutor’s Scientific work has also led to the publication of the following:
Zumutor Biologics Inc. is a niche, innovation driven biologics company registered in the state of Delaware, with its office in Woburn, MA. Expertise and acumen of the Zumutor team is focused on development of new products through patent-pending technology platforms in our state of the art R&D facility in India
Zumutor also offers differentiated services ranging from co-development of monoclonal antibodies to recombinant technology based biosimilars